Welt Bio-Molecular Pharmaceutical, LLC

The New York Structural Biology Center is a corporation governed by a Board representing more than 10 institutional members, including the Albert Einstein College of Medicine of Yeshiva University, City University of New York, Memorial Sloan-Kettering Cancer Center and Mount Sinai School of Medicine. It conducts research in the fields of structural genomics and proteomics. The center maintains a more than 22,000-square-foot renovated building that features high-field magnets and a phase II area that accommodates magnets, laboratories, computers, and office and classroom space. The New York Structural Biology Center additionally hosts several seminars and courses related to science and biochemistry. It is located in New York City.

SIGA Technologies applies microbial genomics to the design and development of novel products that prevent and treat infectious diseases, as well as defend against biological warfare agents. With technology platforms in both vaccines and antibiotics, the company s platform technologies include a vaccine delivery system that activates the immune system at the body s mucosal surfaces in order to prevent infection at the earliest possible stage, a surface protein expression system for the cost-effective production of proteins, biothreat rapid response therapeutics that can be rapidly designed on demand for any biological pathogen and virus counterstrike capability technology that can be used to develop safe and effective antivirals by targeting the proteinases which are encoded within all viruses. SIGA Technologies is headquartered in New York.

Cresilon, Inc is a Brooklyn-based company specializing in innovative technology solutions for the medical field. Their flagship product, VETIGEL, is a groundbreaking gel that has revolutionized wound care in veterinary medicine. With a team of experienced professionals and a commitment to excellence, Cresilon, Inc is dedicated to improving the lives of animals through cutting-edge advancements in medical technology. Driven by a passion for innovation, Cresilon, Inc has developed a range of products including TRAUMAGEL and Cresilon, which have become trusted trademarks in the industry. With a focus on research and development, the company continues to push the boundaries of medical science, providing effective solutions for wound healing and beyond.Generated from the website